Home
Syncom Formulations (india) Ltd Board of Directors
Board of Directors at Syncom Formulations (India) Ltd
Ankit Jain
Independent Director
Kedarmal Bankda
Chairman & Wholetime Director
Krishna Neema
Independent Director
Praveen Jindal
Independent Director
Rinki Bankda
Whole-time Director
Key Highlights
- Kedarmal Bankda continues to serve as the Chairman & Wholetime Director in 2024, maintaining the same position as in the previous year.
- Vijay Shankarlal Bankda continues to serve as the Managing Director in 2024, maintaining the same position as in the previous year.
- Rinki Bankda joins the board as Whole-time Director, in a new position in 2024. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- Ruchi Jindal joins the board as Independent Director, in a new position in 2024. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- Vaishali Agrawal joins the board as Company Sec. & Compli. Officer, in a new position in 2024. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
Syncom Formulations (India) Ltd
NSE: SYNCOMFORMUL
Share Price
Last Ten Days Market Price
| Date | Price (₹) | Day Open (₹) | Day High (₹) | Day Low (₹) |
|---|
| 27 Dec 2024 | 19.86 | 19.73 | 20.06 | 19.65 |
| 26 Dec 2024 | 19.81 | 20.1 | 20.3 | 19.65 |
| 24 Dec 2024 | 20.1 | 20.08 | 20.3 | 19.96 |
| 23 Dec 2024 | 20.13 | 20.54 | 20.76 | 20.01 |
| 20 Dec 2024 | 20.41 | 21.28 | 21.35 | 20.32 |
| 19 Dec 2024 | 21.12 | 20.71 | 21.31 | 20.58 |
| 18 Dec 2024 | 21.07 | 21.84 | 21.84 | 20.81 |
| 17 Dec 2024 | 21.51 | 21.68 | 21.84 | 21.47 |
| 16 Dec 2024 | 21.85 | 21.99 | 22.3 | 21.67 |
| 13 Dec 2024 | 21.82 | 21.66 | 22.27 | 21.29 |
| Date |  Price (₹) |
|---|---|
| 27 Dec 2024 | 19.86 |
| 26 Dec 2024 | 19.81 |
| 24 Dec 2024 | 20.1 |
| 23 Dec 2024 | 20.13 |
| 20 Dec 2024 | 20.41 |
| 19 Dec 2024 | 21.12 |
| 18 Dec 2024 | 21.07 |
| 17 Dec 2024 | 21.51 |
| 16 Dec 2024 | 21.85 |
| 13 Dec 2024 | 21.82 |
Company Fundamentals for Syncom Formulations (India) Ltd
Market Cap
1,866 Cr
EPS
0.3
P/E Ratio (TTM)
56.7
P/B Ratio (TTM)
5.9
Day’s High
20.06
Day’s Low
19.65
DTE
0.0
ROE
10.6
52 Week High
27.94
52 Week Low
11.0
ROCE
14.3
Market Price of Syncom Formulations (India) Ltd
1M
1Y
3Y
5Y
Monitoring Syncom Formulations (India) Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.
Syncom Formulations (India) Ltd News Hub
Nifty slips below 24,200 level; Nifty bank shares buck trend; HDFC Bank drops 2.93%
The main equity indices traded with significant losses in mid-afternoon trade. The Nifty dropped bel
Read more
2024-08-13 00:00:00
Syncom Formulations gains after Q1 PAT rises over 73% YoY
Net sales rose by 45.8% year-over-year (YoY) during the quarter to Rs 87.26 crore. Total expenditure
Read more
2024-08-13 00:00:00
Syncom Formulations (India) consolidated net profit rises 73.41% in the June 2024 quarter
Net profit of Syncom Formulations (India) rose 73.41% to Rs 7.63 crore in the quarter ended June 202
Read more
2024-08-12 00:00:00
Syncom Formulations (India) announces board meeting date
Syncom Formulations (India) will hold a meeting of the Board of Directors of the Company on 12 Augus
Read more
2024-08-06 00:00:00
Document
Annual Reports
N/A
Credit Ratings
N/A
Concalls
Data not available
Data not available
FAQs for Board of Directors of Syncom Formulations (India) Ltd
How are members of Syncom Formulations (India) Ltd Board of Directors selected?
Members of the Syncom Formulations (India) Ltd Board of Directors are typically selected based on their expertise, experience, and alignment with Syncom Formulations (India) Ltd’s strategic goals. Appointments are made by the nomination and remuneration committee and approved by shareholders. However, the selection process does vary from company to company.
Can shareholders interact with the Syncom Formulations (India) Ltd Board of Directors?
Shareholders can interact with the Syncom Formulations (India) Ltd Board of Directors during the Annual General Meeting (AGM) and through formal communications or queries submitted to the company wherein they have the opportunity to ask questions and provide feedback on the business. Please note different companies have different protocols for shareholders who want to meet the Board of Directors.
How often does the Syncom Formulations (India) Ltd Board of Directors meet?
The Syncom Formulations (India) Ltd Board of Directors typically meets quarterly. However, special meetings may be summoned as needed to address urgent matters. The frequency can vary depending on business needs and regulatory requirements to ensure ongoing oversight and strategic guidance for the company. A scheduled meeting among the Board of Directors may vary from company to company.
What are the responsibilities of the Syncom Formulations (India) Ltd Board of Directors?
The Syncom Formulations (India) Ltd Board of Directors is responsible for setting strategic goals, overseeing company performance, ensuring effective governance, and safeguarding shareholder interests. They provide high-level guidance on corporate policies and risk management. Additionally, they appoint and evaluate senior management and ensure compliance with legal and regulatory requirements. Please note the roles and responsibilities of the Board of Directors may be different from company to company.
Who are the current members of the Board of Directors at Syncom Formulations (India) Ltd?
The current Board of Directors at Syncom Formulations (India) Ltd includes Kedarmal Bankda( Chairman & Wholetime Director) ,Vijay Shankarlal Bankda( Managing Director) ,Rinki Bankda( Whole-time Director) ,Ruchi Jindal( Independent Director) ,Vaishali Agrawal( Company Sec. & Compli. Officer) . The full list can be found on Syncom Formulations (India) Ltd’s official website or recent corporate filings.
Popular Search
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
